![Webinar Q&A — Next Generation Humanized Mice for Acute Myeloid Leukemia and Natural Killer Cell Therapy Testing | Taconic Biosciences Webinar Q&A — Next Generation Humanized Mice for Acute Myeloid Leukemia and Natural Killer Cell Therapy Testing | Taconic Biosciences](https://www.taconic.com/content/dam/taconic/legacy/taconic-insights/images/study-design-evaluation-pbmc-engraftment-different-mice-strains.png)
Webinar Q&A — Next Generation Humanized Mice for Acute Myeloid Leukemia and Natural Killer Cell Therapy Testing | Taconic Biosciences
![Therapeutic targeting of preleukemia cells in a mouse model of NPM1 mutant acute myeloid leukemia | Science Therapeutic targeting of preleukemia cells in a mouse model of NPM1 mutant acute myeloid leukemia | Science](https://www.science.org/cms/10.1126/science.aax5863/asset/97b42e48-43a2-42f3-8805-88dabed67004/assets/graphic/367_586_f1.jpeg)
Therapeutic targeting of preleukemia cells in a mouse model of NPM1 mutant acute myeloid leukemia | Science
![Mouse models of NPM1-mutated acute myeloid leukemia: biological and clinical implications | Leukemia Mouse models of NPM1-mutated acute myeloid leukemia: biological and clinical implications | Leukemia](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fleu.2014.257/MediaObjects/41375_2015_Article_BFleu2014257_Fig2_HTML.jpg)
Mouse models of NPM1-mutated acute myeloid leukemia: biological and clinical implications | Leukemia
![Frontiers | Macrophages in Acute Myeloid Leukaemia: Significant Players in Therapy Resistance and Patient Outcomes Frontiers | Macrophages in Acute Myeloid Leukaemia: Significant Players in Therapy Resistance and Patient Outcomes](https://www.frontiersin.org/files/Articles/692800/fcell-09-692800-HTML/image_m/fcell-09-692800-g001.jpg)
Frontiers | Macrophages in Acute Myeloid Leukaemia: Significant Players in Therapy Resistance and Patient Outcomes
Cellular Intrinsic Mechanism Affecting the Outcome of AML Treated with Ara-C in a Syngeneic Mouse Model | PLOS ONE
![Dissecting the early steps of MLL induced leukaemogenic transformation using a mouse model of AML | Nature Communications Dissecting the early steps of MLL induced leukaemogenic transformation using a mouse model of AML | Nature Communications](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41467-020-15220-0/MediaObjects/41467_2020_15220_Fig1_HTML.png)
Dissecting the early steps of MLL induced leukaemogenic transformation using a mouse model of AML | Nature Communications
![Curcumin sensitizes response to cytarabine in acute myeloid leukemia by regulating intestinal microbiota | Cancer Chemotherapy and Pharmacology Curcumin sensitizes response to cytarabine in acute myeloid leukemia by regulating intestinal microbiota | Cancer Chemotherapy and Pharmacology](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs00280-021-04385-0/MediaObjects/280_2021_4385_Fig1_HTML.png)
Curcumin sensitizes response to cytarabine in acute myeloid leukemia by regulating intestinal microbiota | Cancer Chemotherapy and Pharmacology
![CD123 is an excellent target in primary AML in vivo. (A) Primary AML... | Download Scientific Diagram CD123 is an excellent target in primary AML in vivo. (A) Primary AML... | Download Scientific Diagram](https://www.researchgate.net/publication/260528929/figure/fig2/AS:296621662326790@1447731523784/CD123-is-an-excellent-target-in-primary-AML-in-vivo-A-Primary-AML-xenograft-model.png)
CD123 is an excellent target in primary AML in vivo. (A) Primary AML... | Download Scientific Diagram
![Modelling acute myeloid leukemia (AML): What's new? A transition from the classical to the modern | Drug Delivery and Translational Research Modelling acute myeloid leukemia (AML): What's new? A transition from the classical to the modern | Drug Delivery and Translational Research](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs13346-022-01189-4/MediaObjects/13346_2022_1189_Fig2_HTML.png)
Modelling acute myeloid leukemia (AML): What's new? A transition from the classical to the modern | Drug Delivery and Translational Research
![Mouse models of NPM1-mutated acute myeloid leukemia: biological and clinical implications | Leukemia Mouse models of NPM1-mutated acute myeloid leukemia: biological and clinical implications | Leukemia](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fleu.2014.257/MediaObjects/41375_2015_Article_BFleu2014257_Fig1_HTML.jpg)
Mouse models of NPM1-mutated acute myeloid leukemia: biological and clinical implications | Leukemia
![Cancers | Free Full-Text | DJ4 Targets the Rho-Associated Protein Kinase Pathway and Attenuates Disease Progression in Preclinical Murine Models of Acute Myeloid Leukemia Cancers | Free Full-Text | DJ4 Targets the Rho-Associated Protein Kinase Pathway and Attenuates Disease Progression in Preclinical Murine Models of Acute Myeloid Leukemia](https://pub.mdpi-res.com/cancers/cancers-13-04889/article_deploy/html/images/cancers-13-04889-ag.png?1632926767)
Cancers | Free Full-Text | DJ4 Targets the Rho-Associated Protein Kinase Pathway and Attenuates Disease Progression in Preclinical Murine Models of Acute Myeloid Leukemia
![Near-infrared oxidative phosphorylation inhibitor integrates acute myeloid leukemia–targeted imaging and therapy | Science Advances Near-infrared oxidative phosphorylation inhibitor integrates acute myeloid leukemia–targeted imaging and therapy | Science Advances](https://www.science.org/cms/10.1126/sciadv.abb6104/asset/8941c4ea-4484-4cdd-8ef1-e980b2f4ea2e/assets/graphic/abb6104-f4.jpeg)
Near-infrared oxidative phosphorylation inhibitor integrates acute myeloid leukemia–targeted imaging and therapy | Science Advances
![An improved pre-clinical patient-derived liquid xenograft mouse model for acute myeloid leukemia | Journal of Hematology & Oncology | Full Text An improved pre-clinical patient-derived liquid xenograft mouse model for acute myeloid leukemia | Journal of Hematology & Oncology | Full Text](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2Fs13045-017-0532-x/MediaObjects/13045_2017_532_Fig2_HTML.gif)
An improved pre-clinical patient-derived liquid xenograft mouse model for acute myeloid leukemia | Journal of Hematology & Oncology | Full Text
![Sox13 and M2-like leukemia-associated macrophages contribute to endogenous IL-34 caused accelerated progression of acute myeloid leukemia | Cell Death & Disease Sox13 and M2-like leukemia-associated macrophages contribute to endogenous IL-34 caused accelerated progression of acute myeloid leukemia | Cell Death & Disease](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41419-023-05822-z/MediaObjects/41419_2023_5822_Fig1_HTML.png)
Sox13 and M2-like leukemia-associated macrophages contribute to endogenous IL-34 caused accelerated progression of acute myeloid leukemia | Cell Death & Disease
![Animal models of acute lymphoblastic leukemia: Recapitulating the human disease to evaluate drug efficacy and discover therapeutic targets - ScienceDirect Animal models of acute lymphoblastic leukemia: Recapitulating the human disease to evaluate drug efficacy and discover therapeutic targets - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0006295222000648-ga1.jpg)
Animal models of acute lymphoblastic leukemia: Recapitulating the human disease to evaluate drug efficacy and discover therapeutic targets - ScienceDirect
![The Impact of the Cellular Origin in Acute Myeloid Leukemia: Learning From Mouse Models. - Abstract - Europe PMC The Impact of the Cellular Origin in Acute Myeloid Leukemia: Learning From Mouse Models. - Abstract - Europe PMC](https://europepmc.org/articles/PMC6745939/bin/hs9-3-e152-g002.jpg)